Oral contraceptives containing drospirenone for premenstrual syndrome

The Cochrane Database of Systematic Reviews
Laureen M LopezF M Helmerhorst

Abstract

Premenstrual syndrome (PMS) is a common problem. Premenstrual dysphoric disorder (PMDD) is a severe form of premenstrual syndrome. Combined oral contraceptives, which provide both progestin and estrogen, have been examined for their ability to relieve premenstrual symptoms. An oral contraceptive containing drospirenone and a low estrogen dose has been approved for treating PMDD in women who choose oral contraceptives for contraception. To review all randomized controlled trials comparing a combined oral contraceptive containing drospirenone to a placebo or another combined oral contraceptive for effect on premenstrual symptoms. We searched for studies of drospirenone and premenstrual syndrome in the following databases: Cochrane Central Register of Controlled Trials (CENTRAL) (The Cochrane Library), MEDLINE, and POPLINE (20 Dec 2011); EMBASE, LILACS, PsycINFO, ClinicalTrials.gov, and the International Clinical Trials Registry Platform (ICTRP) of the World Health Organization (02 Mar 2011). We also examined references lists of relevant articles and wrote to known investigators to find other trials. We included randomized controlled trials in any language that compared a combined oral contraceptive (COC) containing drospirenone w...Continue Reading

References

Feb 1, 1979·British Journal of Obstetrics and Gynaecology·P M O'BrienE M Symonds
Nov 1, 1968·Psychosomatic Medicine·R H Moos
Nov 1, 1995·Acta Obstetricia Et Gynecologica Scandinavica·M WangT Bäckström
Jan 22, 1998·The New England Journal of Medicine·P J SchmidtD R Rubinow
Oct 30, 1998·Journal of Psychosomatic Research·F BlakeA Garrod
Aug 16, 2000·The European Journal of Contraception & Reproductive Health Care : the Official Journal of the European Society of Contraception·J M FoidartR Heithecker
Sep 20, 2000·Journal of Psychosomatic Obstetrics and Gynaecology·J M GoldingM J King
Sep 18, 2001·Journal of Women's Health & Gender-based Medicine·E W FreemanUNKNOWN PMS/PMDD Research Group
Feb 28, 2002·Lancet·Kenneth F Schulz, David A Grimes
Mar 13, 2002·Lancet·Kenneth F Schulz, David A Grimes
Apr 27, 2002·Journal of Women's Health & Gender-based Medicine·Deborah Megivern
Jun 14, 2002·Journal of Reproductive Immunology·Z StrakovaA T Fazleabas
Dec 18, 2002·Statistics in Medicine·Alan Phillips, Vincent Haudiquet
May 31, 2003·BMJ : British Medical Journal·Joel LexchinOtavio Clark
Aug 21, 2003·JAMA : the Journal of the American Medical Association·Bodil Als-NielsenLise L Kjaergard
May 12, 2004·Molecular and Cellular Endocrinology·Wolfgang Oelkers
Jul 13, 2005·Education for Health : Change in Training & Practice·Joachim Sturmberg
Sep 2, 2005·Obstetrics and Gynecology·Kimberly A YonkersAndrea Rapkin
Sep 21, 2005·Archives of Women's Mental Health·J EndicottW Harrison
Oct 6, 2005·Climacteric : the Journal of the International Menopause Society·J-M Foidart
Oct 6, 2005·Archives of Women's Mental Health·N Kurshan, C Neill Epperson
Nov 18, 2005·Human Reproduction Update·Regine Sitruk-Ware
Jun 6, 2006·Acta Obstetricia Et Gynecologica Scandinavica·Diaa E E RizkNico Nagelkerke
Jun 27, 2006·American Journal of Obstetrics and Gynecology·Andrea L CoffeePatricia J Sulak
Mar 6, 2007·Nihon eiseigaku zasshi. Japanese journal of hygiene·Sumiko Ishizu, Chise Hashida
Sep 1, 2007·The European Journal of Contraception & Reproductive Health Care : the Official Journal of the European Society of Contraception·Jan EndrikatMichel Fortier
Aug 12, 2008·Lancet·F M HelmerhorstA A Kaptein
Apr 17, 2009·The Cochrane Database of Systematic Reviews·Olive FordBen Willem J Mol
May 11, 2010·American Journal of Obstetrics and Gynecology·Roger K Freeman, Michael P Nageotte

❮ Previous
Next ❯

Citations

Jun 1, 2012·Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology·Gianni AllaisChiara Benedetto
Aug 13, 2014·Archives of Women's Mental Health·Keely Cheslack-PostavaKarestan C Koenen
Mar 4, 2017·The Cochrane Database of Systematic Reviews·Bushra NaheedPatrick Michael Shaughn O'Brien
Jun 8, 2013·The Cochrane Database of Systematic Reviews·Jane MarjoribanksKatrina Wyatt
Feb 21, 2018·Archives of Suicide Research : Official Journal of the International Academy for Suicide Research·Daisung Jang, Hillary Anger Elfenbein
Oct 3, 2012·Annals of Internal Medicine·Elisabeth J Woodhams, Melissa Gilliam
Oct 19, 2019·Current Psychiatry Reports·Jessica R Peters, Tory A Eisenlohr-Moul
May 29, 2019·Journal of Midwifery & Women's Health·Amy AlspaughShannon Phillips
Nov 18, 2017·Psychological Medicine·Nicole PetersenEdythe D London
Sep 13, 2018·International Journal of Environmental Research and Public Health·Keisha SmithTultul Nayyar
May 28, 2019·Health and Quality of Life Outcomes·Fatima Leon-LariosM Nieves Cabezas-Palacios
Jul 6, 2016·Archives of Women's Mental Health·Elgerta IsmailiUNKNOWN Consensus Group of the International Society for Premenstrual Disorders
Oct 10, 2021·Current Psychiatry Reports·Christine Kuehner, Sibel Nayman

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.